About Bardy Diagnostics
Bardy Diagnostics is a Healthcare company based in Charlotte (United States) founded in 2013, and was acquired by Hillrom in January 2021. It develops and markets the Carnation Ambulatory Monitor. It operates in the Healthcare and Technology sectors. Bardy Diagnostics has raised $83.39 million across 4 funding rounds from investors including Health Enterprise Partners, Square 1 Bank and SV Health Investors. Bardy Diagnostics offers products and services including CAM Patch, BDxCONNECT, and CAM Report. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Monitoring Devices. Its legal entity is BARDY DIAGNOSTICS, INC. Its competitors include iRhythm Tech, Ekso Bionics and Endotronix; 3 of its 3 listed competitors have raised funding.
Company details
Bardy Diagnostics was founded in 2013 in Charlotte, United States. Operations are centered on the development and marketing of the Carnation Ambulatory Monitor, a P-wave centric device used for ambulatory cardiac monitoring and arrhythmia detection. The monitor is designed to be worn for up to seven days, providing cardiologists with tools for precise diagnosis in the medical device sector.
- Total Equity Funding$83.39M (USD)
in 4 rounds
- Latest Funding Round$12.49M (USD), Series B
Feb 2020
- InvestorsHealth Enterprise Partners
& 10 more
- Acquired byHillrom
(Jan 2021)
Products & Services of Bardy Diagnostics
Bardy Diagnostics offers a comprehensive portfolio of products and services, including CAM Patch, BDxCONNECT, and CAM Report.
Lightweight patch for extended cardiac monitoring and accurate P-wave capture.
Cloud platform for uploading and analyzing ECG data from devices.
Generates detailed ECG reports for quick arrhythmia interpretation.
Apps and channels of Bardy Diagnostics
its YouTube channel Bardy Diagnostics Inc has 385 subscribers and 4 videos.
Videos from Bardy Diagnostics
The most watched videos on Bardy Diagnostics's YouTube channel, Bardy Diagnostics Inc (385 subscribers). Click a video to play it here.
More on Bardy Diagnostics Inc.
Funding Insights of Bardy Diagnostics
Bardy Diagnostics has successfully raised a total of $83.39M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $12.49 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $83.39M
- Total Rounds 4
- Last Round Series B — $12.49M
- First Round $35.36M
(Jun 2018)
- Investors Count 10
All 4 funding rounds of Bardy Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $12.49M | Series B | – | – | – |
| Jan 2019 | $35.53M | Series B | – | River Cities Capital | |
| Jul 2018 | Series B | – | SV Health Investors, Health Enterprise Partners | – | |
| Jun 2018 | $35.36M | Series B | – | Square 1 Bank, Ascension Ventures | – |
11 investors in total: 11 institutional.
Investors in Bardy Diagnostics
Bardy Diagnostics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Health Enterprise Partners, Square 1 Bank and SV Health Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Investments are focused on healthcare and information technology sectors. | 1999 | hepfund.com | New York, United States | |
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
| rccf.com | ||||
Investments are focused on tech and life sciences startups. | healthquestcapital.com | Belmont, United States | ||
A healthcare-focused investment firm supporting innovative company growth. | aperturevp.com | |||
Tech and life sciences focused VC firm investing in geographies such as the US | aphelioncapital.net | Mill Valley, United States | ||
Lumira Ventures is engaged in life sciences venture capital investment. | lumiraventures.com | Toronto, Canada | ||
| rexhealthventures.com | ||||
Venture debt, treasury, and cash management services are provided. | 2005 | square1bank.com | Durham, United States |
Investor details for Bardy Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bardy Diagnostics
37 people are tracked at Bardy Diagnostics (4 in leadership, 33 in team).
| Name | Role | Group |
|---|---|---|
Mark Querry | CFO | Leadership |
Erik Sorenson | Regional Sales Director - Midwest North Region | Leadership |
Corey McClain | Regionals Sales Director | Leadership |
Jay Medenilla | Director - US East Sales | Leadership |
Jennifer Martin | Sr. Account Executive-corporate Accounts And IDN Strategy | Team |
Heather C. | Senior Manager Field Clinical Services & Sales Training | Team |
Jeffrey Hansen | Senior Account Executive | Team |
Kevin Silva | Account Executive | Team |
Rick Demarco | Account Executive | Team |
Taylor Hall | Account Executive | Team |
Allyson Ramer | Account Executive | Team |
Patrick Sullivan | Principal Software Engineer | Team |
Caroline Rose | Account Executive | Team |
Amisha Patel | Senior Software Engineer - Front End | Team |
Jeremy Drew | Senior Software Business Analyst | Team |
Garrett Englert | Account Executive | Team |
Alina Lapene | Senior Account Executive | Team |
Jason Ritter | Regional Sales Manager | Team |
John Coughlin | Account Executive | Team |
Samer Kishta | Senior Quality Engineer | Team |
17 more people are available in the full profile.
Complete people profiles for Bardy Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bardy Diagnostics
4 dated milestones of Bardy Diagnostics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Bardy Diagnostics is founded.
- Funding First funding round of $35.4M.
- Funding Latest funding round, Series B, of $12.5M.
- Exit Acquired by Hillrom.
Competitors of Bardy Diagnostics
Bardy Diagnostics has 3 listed competitors in our database, 3 of them funded. They include iRhythm Tech, Ekso Bionics and Endotronix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| irhythmtech.com | 2006 | San Francisco, United States | $109.23M | 1,657 | Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | |
| eksobionics.com | 2005 | United States | $24.37M | 56 | Exoskeletons for medical rehabilitation and industrial productivity are provided. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. |
Detailed competitors of Bardy Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bardy Diagnostics
The website of Bardy Diagnostics (bardydx.com) receives about 9.9K visits a month.
- Monthly visits9.9K
▲ 91.4% vs previous month
Websites whose visitors overlap most with Bardy Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| baxter.com | 100% | 401.8K | #127,908 | View details | |
| reachmd.com | 92% | #448,293 | View details | ||
| practiceupdate.com | 80% | View details |
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Bardy Diagnostics (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bardy Diagnostics
Complete news archive for Bardy Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bardy Diagnostics
Bardy Diagnostics was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Bardy Diagnostics is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.
Bardy Diagnostics is a funded company, having raised a total of $83.39M across 4 funding rounds to date. The company's 1st funding round was a Series B of $35.36M, raised on Jun 2018.
Bardy Diagnostics was founded in 2013 in Charlotte, United States. Operations are centered on the development and marketing of the Carnation Ambulatory Monitor, a P-wave centric device used for ambulatory cardiac monitoring and arrhythmia detection. The monitor is designed to be worn for up to seven days, providing cardiologists with tools for precise diagnosis in the medical device sector.
Bardy Diagnostics's top competitors include iRhythm Tech, Endotronix and Ekso Bionics.
Bardy Diagnostics offers CAM Patch, BDxCONNECT, and CAM Report.
Bardy Diagnostics has 11 investors. Key investors include Health Enterprise Partners, Square 1 Bank, SV Health Investors, Ascension Ventures, and River Cities Capital.
Bardy Diagnostics operates through Bardy Diagnostics, Inc.
Yes. Bardy Diagnostics was acquired by Hillrom in January 2021.